Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Cancer Globally (Vol. 1, Issue 1)

Cancer Globally (Vol. 1, Issue 1)

Sep 05, 2017

Cancer by Numbers provide us with the degree of devastation it has incurred among various populations, and provides us with a better idea on the level of progress needed to eradicate this morbid indication. It also sheds light on the blockbuster drugs along with potential therapies for the cancer.

Click Here For Downloading the latest Newsletter

Downloads

Article in PDF

Recent Articles
  1. Telomerase Inhibitors – An Anti Cancer Approach
  2. Harmony in Treatment: GOLCA (golcadomide) Reveals Favorable Safety Profile and Seamless Integrati...
  3. Notizia
  4. Breaking Ground: Ibrutinib and Venetoclax Synergy Delivers Significant Progression-Free Survival ...
  5. Virtual Reality Maps Helps Doctors Understand Cancer Tumor Structure
medtech-news-of-cartessa-logicmark-boston-scientific
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Cartessa Aesthetics teams with Classys for Everesse; LogicMark unveils Freedom Alert Max; GE HealthCare clears SIGNA MAGNUS MRI; OMRON’s BP monitor with AI-powered AFib detection gets FDA approval; Boston Scientific’s WATCHMAN FLX™ cuts bleeding risk; Encora Therapeutics wraps ULTRE trial for tremor device

Cervical Cancer Current Scenario
Articles

Cervical Cancer: Current Scenario

Pharma-news-for-bms-intrabio-pfizer
Notizia - Recent Pharma, Healthcare and Biotech Happenings

IntraBio’s AQNEURSA Niemann-Pick Disease Approval; FDA Approves Novel Schizophrenia Drug After 35 Years; Selpercatinib Gets FDA Nod for RET-Mutated MTC; DUPIXENT Receives First-Ever COPD Approval; Pfizer Withdraws OXBRYTA for Sickle Cell Disease from Global Market

Cancer
cancer drugs
cancer infographic
cancer statistics
Cancer therapies
top cancer
loader